MedPlus Mart’s Tech Fuels 166% Profit Growth in India

MedPlus Mart’s technology-driven strategy is demonstrably reshaping India’s fragmented pharmacy retail market, evidenced by its significant financial growth in Q2 FY25. The company’s net profit surged 165.97% year-on-year, underscoring the efficacy of its integrated operational model.

Strategic Expansion Driven by Data

Founded in 2006 by Gangadi Madhukar Reddy, MedPlus initially targeted India’s issue with counterfeit medicines, building its reputation on trust and transparent pricing. The company adopted a “cluster-based” store expansion, saturating urban areas before expanding outwards.

• By September 2021, MedPlus had expanded to over 2,300 stores.
• Its e-commerce platform, MedPlusMart.com, launched in 2015, contributed approximately 9% of total revenue by FY2021.
• The company went public in December 2021, successfully raising approximately ₹1,398 crore.
• Future plans project growth to 5,200–5,500 stores across 12–14 states by 2024–2026.

MedPlus’s strategic objectives include boosting store penetration and developing its omnichannel platform with a “hyper-local” delivery model. It also aims to increase private-label product share and enhance overall operating efficiency.

Integrated Operational Architecture

An in-house integrated technology infrastructure underpins MedPlus’s entire business value chain, from procurement and warehousing to billing and last-mile delivery. This system supports automated replenishment and stock-picking, minimizing errors and stock-outs.

• Store expansion is precisely guided by data analytics.
• A self-managed last-mile delivery fleet enables two-hour delivery in select cities.
• Private-label products, which represented over 10% of revenue at IPO, grew to 21.5% by Q2 FY26.
• MedPlus also operates adjacent digital verticals, including MedPlus Labs for diagnostics and MedPlus Lens for optical retail.

Key Financial Performance Metrics

• FY2021 Average Revenue per Store: Approximately ₹1.59 crore, significantly surpassing the industry average.
• FY23 Consolidated Revenue: Approximately ₹4,603 crore, with a net income of about ₹49 crore.
• FY24 Operating Profit Growth: 32.0% year-on-year, achieving an operating margin of 6.6% and a net profit margin of 1.2%.
• Q2 FY25 Net Profit: Surged 165.97% year-on-year to ₹38.74 crore.
• Q2 FY25 Revenue: Increased 11.9% to ₹1,576.17 crore.

The company maintains a strong market positioning centered on trust and affordability, offering standardized discounts to customers. This strategy, combined with its cluster-based expansion, capitalizes on consumer demand for proximity and immediate access to pharmacy services.

MedPlus Mart’s consistent leveraging of technology as a core infrastructure element continues to drive favorable unit economics and substantial growth within India’s competitive retail pharmacy sector.